FBR Capital Starts Sarepta Therapeutic (SRPT) at Market Perform
Tweet Send to a Friend
FBR Capital initiates coverage on Sarepta Therapeutic (NASDAQ: SRPT) with a Market Perform. PT $48.00.
Analyst William Tanner, Ph.D ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst William Tanner, Ph.D ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
